Duchenne Development: Data Sharing May Enable Trials To Move Beyond Six-Minute Walk

Repeated trial failures in this rare disease space have given birth to new alliances – one backed by Critical Path and the other by the CureDuchenne advocacy group – that aim to model disease progression much more accurately through data sharing and rigorous analysis.